Xiao-Jing Du

941 total citations · 1 hit paper
9 papers, 677 citations indexed

About

Xiao-Jing Du is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiao-Jing Du has authored 9 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Otorhinolaryngology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiao-Jing Du's work include Head and Neck Cancer Studies (7 papers), Brain Metastases and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Xiao-Jing Du is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Brain Metastases and Treatment (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Xiao-Jing Du collaborates with scholars based in China, United States and Cuba. Xiao-Jing Du's co-authors include Jun Ma, Ying Sun, Ai-Hua Lin, Ling‐Long Tang, Lei Chen, Wen-Fei Li, Guan‐Qun Zhou, Yan-Ping Mao, Yu‐Pei Chen and Chiun Hsu and has published in prestigious journals such as PLoS ONE, Scientific Reports and BMJ.

In The Last Decade

Xiao-Jing Du

9 papers receiving 670 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

2018 416 citations Cheng Xu, Yu‐Pei Chen et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiao-Jing Du China	8	497	194	164	145	103	9	677
Amaury Daste France	13	610 1.2×	279 1.4×	173 1.1×	167 1.2×	173 1.7×	66	848
Wang‐Zhong Li China	13	275 0.6×	116 0.6×	205 1.3×	129 0.9×	58 0.6×	41	523
A. Psyrri Greece	9	300 0.6×	193 1.0×	225 1.4×	197 1.4×	42 0.4×	23	814
E. del Barco Spain	17	341 0.7×	260 1.3×	149 0.9×	95 0.7×	34 0.3×	66	629
Su Jung Shim South Korea	14	294 0.6×	156 0.8×	110 0.7×	303 2.1×	50 0.5×	34	819
Virginia Arrazubi Spain	12	372 0.7×	235 1.2×	34 0.2×	155 1.1×	52 0.5×	48	641
Xue-Song Sun China	13	275 0.6×	190 1.0×	378 2.3×	195 1.3×	38 0.4×	51	621
Linda Feeley Ireland	14	291 0.6×	71 0.4×	214 1.3×	230 1.6×	86 0.8×	38	670
Chi‐Chung Tong China	13	271 0.5×	136 0.7×	286 1.7×	230 1.6×	35 0.3×	31	590

Countries citing papers authored by Xiao-Jing Du

Since Specialization

Citations

This map shows the geographic impact of Xiao-Jing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Jing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Jing Du more than expected).

Fields of papers citing papers by Xiao-Jing Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Jing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Jing Du. The network helps show where Xiao-Jing Du may publish in the future.

Co-authorship network of co-authors of Xiao-Jing Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Jing Du. A scholar is included among the top collaborators of Xiao-Jing Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Jing Du. Xiao-Jing Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wang, Yaqin, Jia-Wei Lv, Ling‐Long Tang, et al.. (2019). Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual. Oral Oncology. 90. 23–29. 9 indexed citations

2.

Du, Xiao-Jing, Si-Yang Wang, Fangfang Chen, et al.. (2019). Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial. Journal of Cancer. 10(14). 3214–3223. 27 indexed citations

3.

Xu, Cheng, Yu‐Pei Chen, Xiao-Jing Du, et al.. (2018). Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis. BMJ. 363. k4226–k4226. 416 indexed citations breakdown →

4.

Chen, Lei, Yuan Zhang, Wen-Fei Li, et al.. (2018). 10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma. The Oncologist. 24(1). e38–e45. 59 indexed citations

5.

Liu, Xu, Ling‐Long Tang, Xiao-Jing Du, et al.. (2017). Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up. Journal of Cancer. 8(3). 455–459. 37 indexed citations

6.

Du, Xiao-Jing, Ling‐Long Tang, Yan‐Ping Mao, et al.. (2016). Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma. Journal of Cancer. 7(6). 664–670. 26 indexed citations

7.

Du, Xiao-Jing, et al.. (2016). Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. PLoS ONE. 11(1). e0146787–e0146787. 6 indexed citations

8.

Du, Xiao-Jing, Ling‐Long Tang, Yan‐Ping Mao, et al.. (2015). Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma. Journal of Translational Medicine. 13(1). 364–364. 66 indexed citations

9.

Du, Xiao-Jing, Ling‐Long Tang, Lei Chen, et al.. (2015). Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy. Scientific Reports. 5(1). 16664–16664. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact